US Patent Issued to Mozarc Medical US on April 29 for "Precision dialysis therapy based on sorbent effluent analysis" (Minnesota Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,552, issued on April 29, was assigned to Mozarc Medical US LLC (Minneapolis).

"Precision dialysis therapy based on sorbent effluent analysis" was invented by Bryant J. Pudil (Plymouth, Minn.), Christopher M. Hobot (Rogers, Minn.) and Martin T. Gerber (Maple Grove, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to devices, systems, and methods for preforming a precision dialysis therapy session based on an analysis of an effluent from a zirconium phosphate sorbent module during an ammonium removal process. The settings for the precision dialysis therapy session can be obtained by estimating a patient's physiological state, ...